3-[4-[(3-methyl-3,8-diazabicyclo[3.2.1]octan-8-yl)methyl]phenyl]-5-(3-methylphenyl)-7H-cyclopenta[b]pyridine
C29H31N3 — CID 159840719
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[4-[(3-methyl-3,8-diazabicyclo[3.2.1]octan-8-yl)methyl]phenyl]-5-(3-methylphenyl)-7H-cyclopenta[b]pyridine
3-[4-[(3-methyl-3,8-diazabicyclo[3.2.1]octan-8-yl)methyl]phenyl]-5-(3-methylphenyl)-7H-cyclopenta[b]pyridine (PubChem CID 159840719) has the molecular formula C29H31N3 and a molecular weight of 421.59 g/mol. Its IUPAC name is 3-[4-[(3-methyl-3,8-diazabicyclo[3.2.1]octan-8-yl)methyl]phenyl]-5-(3-methylphenyl)-7H-cyclopenta[b]pyridine.
Molecular Properties
| Compound Name | 3-[4-[(3-methyl-3,8-diazabicyclo[3.2.1]octan-8-yl)methyl]phenyl]-5-(3-methylphenyl)-7H-cyclopenta[b]pyridine |
|---|---|
| PubChem CID | 159840719 |
| Molecular Formula | C29H31N3 |
| Molecular Weight | 421.59 g/mol |
| Exact Mass | 421.25 |
| IUPAC Name | 3-[4-[(3-methyl-3,8-diazabicyclo[3.2.1]octan-8-yl)methyl]phenyl]-5-(3-methylphenyl)-7H-cyclopenta[b]pyridine |
| SMILES | Cc1cccc(C2=CCc3ncc(-c4ccc(CN5C6CCC5CN(C)C6)cc4)cc32)c1 |
| InChI | InChI=1S/C29H31N3/c1-20-4-3-5-23(14-20)27-12-13-29-28(27)15-24(16-30-29)22-8-6-21(7-9-22)17-32-25-10-11-26(32)19-31(2)18-25/h3-9,12,14-16,25-26H,10-11,13,17-19H2,1-2H3 |
| InChIKey | AIUMKMBBKIIAPZ-UHFFFAOYSA-N |
| XLogP | 5.32 |
| TPSA | 19.37 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 421.59 |
| LogP ≤ 5 | 5.32 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159840719 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.